MIRA INFORM
REPORT
|
Report Date : |
07.04.2011 |
IDENTIFICATION DETAILS
|
Name : |
BADR DRUGS & CHEMICALS CO LTD |
|
|
|
|
Registered Office : |
Building No. 428,
Block No. 21, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Year of Establishment : |
1986 |
|
|
|
|
Com. Reg. No.: |
1124, |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Distributors of pharmaceuticals, medicines and drugs |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 150,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
c1 |
c1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SUMMARY
Company Name : BADR DRUGS & CHEMICALS CO LTD
Country of Origin :
Legal Form : Limited Liability Company
Registration Date : 1986
Commercial Registration Number : 1124,
Issued Capital : SD 5,000,000
Paid up Capital : SD 5,000,000
Total Workforce : 38
Activities : Distributors of pharmaceuticals, medicines and drugs.
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Recommended Credit Limit : US$ 150,000
COMPANY NAME
BADR DRUGS & CHEMICALS CO LTD
company ADDRESS
Registered & Physical Address
Building : Building No. 428, Block No. 21
Street :
PO Box : 4220
Town :
Country :
Telephone : (249-183) 520506 / 520208 / 520211
Facsimile : (249-183) 520209
Email : badrbash@hotmail.com / info@badrdrugs.com
Premises
Subject operates
from a small suite of offices that are rented and located in the Central
Business Area of Khartoum.
KEY PRINCIPALS
Name Position
·
Bashir
Hassan Bashir Managing
Director
·
Dr
Badruddine Mohamed Ibrahim Director
·
Dr
Ahmed Hussain Ghattas Director
·
Mohamed
Faisal Director
·
Dr
Osama Al Tayeb Sarour Commercial
Manager
·
Mohamed A Al Shareif Purchasing
Manager
LEGAL FORM & OWNERS
Date of Establishment : 1986
Legal Form :
Limited Liability Company
Commercial Reg. No. : 1124,
Issued Capital : SD 5,000,000
Paid up Capital : SD 5,000,000
Name of Shareholder
(s)
·
Bashir
Hassan Bashir
·
Dr
Badruddine Mohamed Ibrahim
·
Dr
Ahmed Hussain Ghattas
·
Mohamed
Faisal
OPERATIONS
Activities: Engaged in the import and distribution of
pharmaceuticals, medicines and drugs.
Import
Countries: Europe and the
Agencies Held:
·
Lyka
Labs Ltd
·
Tubilux
Pharma
·
United
Pharmaceutical Company
·
Asia
Laboratories for Pharmaceutical Industries
·
Glenmark
Operating Trend: Steady
Subject has a
workforce of 38 employees.
FINANCIAL DATA
Financial
highlights provided by local sources are given below:
Currency: Sudanese
Dinars (SD)
Year
Ending 31/12/09: Year
Ending 31/12/10:
Total Sales SD 8,750,000 SD 9,110,000
Local sources
consider subject’s financial condition to be Fair.
The above financial
figures are based on estimations by our local sources.
BANKERS
·
Saudi
Sudanese Bank
Horia Branch
Tel: (249-183) 776700
PAYMENT HISTORY
No complaints
regarding subject’s payments have been reported.
GENERAL COMMENTS
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.22 |
|
|
1 |
Rs.72.25 |
|
Euro |
1 |
Rs.63.09 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.